Resurse
Articole recomandate
Articol: ”The Conundrum of Lung Disease and Drug Hypersensitivity-like Reactions in Systemic Juvenile Idiopathic Arthritis.”
Autori: Binstadt BA, Nigrovic PA.Arthritis Rheumatol. 2022 Jul;74(7):1122-1131. doi: 10.1002/art.42137.
Link util: https://pubmed.ncbi.nlm.nih.gov/35413159/
Articol: ”Identification of Distinct Inflammatory Programs and Biomarkers in Systemic Juvenile Idiopathic Arthritis and Related Lung Disease by Serum Proteome Analysis.”
Autori: Chen G, Deutsch GH, Schulert GS, Zheng H, Jang S, Trapnell B, Lee PY, Macaubas C, Ho K, Schneider C, Saper VE, de Jesus AA, Krasnow MA, Grom A, Goldbach-Mansky R, Khatri P, Mellins ED, Canna SW.
Arthritis Rheumatol. 2022 Jul;74(7):1271-1283. doi: 10.1002/art.42099.
Link util: https://pubmed.ncbi.nlm.nih.gov/35189047/
Articol: ”Role for Granulocyte Colony-Stimulating Factor in Neutrophilic Extramedullary Myelopoiesis in a Murine Model of Systemic Juvenile Idiopathic Arthritis.”
Autori: Malengier-Devlies B, Bernaerts E, Ahmadzadeh K, Filtjens J, Vandenhaute J, Boeckx B, Burton O, De Visscher A, Mitera T, Berghmans N, Verbeke G, Liston A, Lambrechts D, Proost P, Wouters C, Matthys P.
Arthritis Rheumatol. 2022 Jul;74(7):1257-1270. doi: 10.1002/art.42104.
Link util: https://pubmed.ncbi.nlm.nih.gov/35243819/
Articol: ”MRP8/14 serum levels as diagnostic markers for systemic juvenile idiopathic arthritis in children with prolonged fever.”
Autori: Park C, Miranda-Garcia M, Berendes R, Horneff G, Kuemmerle-Deschner J, Ganser G, Huppertz HI, Minden K, Haas JP, Jansson AF, Borte M, Schuetz C, Oommen P, Frosch M, Schlueter B, Richter-Unruh A, Kessel C, Hinze C,ittkowski H, Roth J, Foell D, Holzinger D.
Rheumatology (Oxford). 2022 Jul 6;61(7):3082-3092. doi: 10.1093/rheumatology/keab729.
Link util: https://pubmed.ncbi.nlm.nih.gov/34559193/
Articol: ”Nonspecific interstitial pneumonia in refractory systemic juvenile idiopathic arthritis responded to tocilizumab treatment.”
Autori: Sukharomana M, Udomittipong K, Ruangchira-Urai R, Charuvanij S.
Asian Pac J Allergy Immunol. 2022 Jun;40(2):172-176. doi: 10.12932/AP-050819-0616.
Link util: https://pubmed.ncbi.nlm.nih.gov/31837211/
Articol: ”Adult-Onset and Juvenile-Onset Still’s Disease: A comparative study of both sides.”
Autori: Ben Tekaya A, Hannech E, Saidane O, Bouden S, Rouached L, Tekaya R, Mahmoud I, Abdelmoula S, Abdelmoula L.
Curr Rheumatol Rev. 2022 Jun 17. doi: 10.2174/1573397118666220617101447. Online ahead of print.
Link util: https://pubmed.ncbi.nlm.nih.gov/35718964/
Articol: ”Systemic Juvenile Idiopathic Arthritis in two children; case report on clinical course, challenges in diagnosis and the role of FDG-PET/CT-scan.”
Autori: Sahba S, Huurnink A, Van den Berg JM, Tuitert B, Vastert SJ, Ten Tusscher GW.
Clin Case Rep.2022 Jun 13;10(6):e05900. doi: 10.1002/ccr3.5900. eCollection 2022 Jun.
Link util: https://pubmed.ncbi.nlm.nih.gov/35734189
Articol: ”Lung Ultrasound in Children with Systemic Juvenile Idiopathic Arthritis Associated Interstitial Lung Disease.”
Autori: Vega-Fernandez P, Ting TV, Mar DA, Schapiro AH, Deluna MD, Saper VE, Grom AA, Schulert GS, Fairchild RM.
Arthritis Care Res (Hoboken). 2022 May 23. doi: 10.1002/acr.24957. Online ahead of print.
Link util: https://pubmed.ncbi.nlm.nih.gov/35604884/
Methotrexate in juvenile idiopathic arthritis: advice and recommendations from the MARAJIA expert consensus meeting
Ferrara G, Mastrangelo G, Barone P si colaboratorii (Pediatric Rheumatology Online Journal. 2018)
Acceseaza articol, tabele si recomandari
Protocols on classification, monitoring and therapy in children’s rheumatology (PRO-KIND): results of the working group Polyarticular juvenile idiopathic arthritis
Descarca PDF
2017 European League Against Rheumatism/ American College of Rheumatology classification criteria for adult and juvenile idiopathic in ammatory myopathies and their major subgroups
Lundberg IE, et al. Ann Rheum Dis 2017;76:1955–1964.
Clinical Juvenile Arthritis Disease Activity Score proves to be a useful tool in treat-to-target therapy in juvenile idiopathic arthritis
Swart JF, et al. Ann Rheum Dis 2017;0:1–7.
Descarca PDF
European evidence-based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus: the SHARE initiative
Groot N, et al. Ann Rheum Dis 2017;76:1788–1796
Descarca PDF
European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiative
Groot N, et al. Ann Rheum Dis 2017;76:1965–1973.
Descarca PDF
European evidence-based recommendations
for diagnosis and treatment of paediatric antiphospholipid syndrome: the SHARE initiative
Groot N, et al. Ann Rheum Dis 2017;76:1637–1641
Descarca PDF
Ringold S, et al. 2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications.
Arthritis Care Res (Hoboken). 2013;65(10):1551-63.
Ringold S et al. 2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications.
Arthritis Rheum. 2013;65(10):2499-512.
Beukelman T et al. 2011 American College of Rheumatology Recommendations for
the Treatment of Juvenile Idiopathic Arthritis: Initiation and Safety Monitoring of Therapeutic Agents for the Treatment of Arthritis and Systemic Features.
Arthritis Care Res (Hoboken). 2011; 63(4): 465–482.
DeWitt EM et al. Consensus Treatment Plans for New-Onset Systemic Juvenile
Idiopathic Arthritis.
Arthritis Care Res (Hoboken). 2012; 64(7): 1001–1010
Li S et al. Development of Consensus Treatment Plans for Juvenile Localized Scleroderma: A roadmap toward comparative effectiveness studies in juvenile localized scleroderma.
Arthritis Care Res (Hoboken). 2012; 64(8): 1175–1185.
Annals of Pediatric Rheumatology Annals of the Pediatric Rheumatology (APR) is an international peer review journal committed to promoting the highest standards of scientific exchange and education. It attemps to cover all various aspects of paediatric rheumatology for its readers, which encompassing the spectrum of diseases with arthritis, musculoskeletal conditions, autoinflammatory diseases, connective tissue disorders, translational research, the latest therapies and treatment programs. This journal publishes original articles, concise reports, reviews, editorials, guidelines, case reports, clinical vignettes and letters. Matters arising from published material. Peer reviewed proceedings of international meetings are also featured. Reviews, new developments or controversial issues in the field, through invited contributions from recognized authorities , are discussed here.
